Recombinant Human Spasmolytic Polypeptide protein (ab50085)
製品の概要
-
製品名Recombinant Human Spasmolytic Polypeptide protein
Spasmolytic Polypeptide タンパク質・ペプチド 製品一覧 -
タンパク質長Full length protein
製品の詳細
-
由来Recombinant
-
由来Escherichia coli
-
アミノ酸配列
-
アクセッション番号
-
生物種Human
-
配列AEKPSPCQCSR LSPHNRTNCG FPGITSDQCF DNGCCFDSSV TGVPWCFHPL PKQESDQCVM EVSDRRNCGY PGISPEECAS RKCCFSNFIF EVPWCFFPKS VEDCHY
-
分子量12 kDa
-
領域23 to 129
-
特性
Our Abpromise guarantee covers the use of ab50085 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
-
アプリケーション
SDS-PAGE
Functional Studies
-
エンドトキシン・レベル< 0.100 Eu/µg
-
精製度> 95 % SDS-PAGE.
ab50085 ppurity was assessed also by HPLC. Endotoxin level is less than 0.1 ng per µg (1EU/µg). -
製品の状態Lyophilised
-
Concentration information loading...
前処理および保存
-
保存方法および安定性
Shipped at 4°C. The lyophilized protein is stable for a few weeks at room temperature. Store at -20°C long term.
関連情報
-
別名
- SML 1
- SML1
- SP
see all -
機能Inhibits gastrointestinal motility and gastric acid secretion. Could function as a structural component of gastric mucus, possibly by stabilizing glycoproteins in the mucus gel through interactions with carbohydrate side chains.
-
組織特異性Stomach.
-
配列類似性Contains 2 P-type (trefoil) domains.
-
細胞内局在Secreted.
- Information by UniProt
Recombinant Human Spasmolytic Polypeptide protein (ab50085) 使用論文
ab50085 has not yet been referenced specifically in any publications.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"